Oral v. topical erythromycin therapies for chlamydial conjunctivitis

P. Patamasucon, P. J. Rettig, K. L. Faust, H. T. Kusmiesz, J. D. Nelson

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Results of oral and topical erythromycin therapy in 41 infants under 4 months of age with chlamydial conjunctivitis were evaluated in a randomized clinical trial. After three weeks of treatment, relapse or reinfection of the eye occurred in four of 19 patients (21%) in the topical therapy group and in three of 22 patients (13.6%) in the oral therapy group (P < .69). In the topical therapy group, chlamydiae were isolated from nasopharyngeal cultures of eight patients (42%) during or after therapy. Chlamydiae were eradicated from the nasopharynx of the six colonized patients treated with oral erythromycin. All relapses responded to a course of oral erythromycin therapy. We conclude that both modes of therapy are comparable for treatment of chlamydial conjunctivitis, but that oral therapy has the advantage of eradicating nasopharyngeal colonization.

Original languageEnglish (US)
Pages (from-to)817-821
Number of pages5
JournalAmerican Journal of Diseases of Children
Volume136
Issue number9
StatePublished - 1982

Fingerprint

Conjunctivitis
Erythromycin
Group Psychotherapy
Chlamydia
Therapeutics
Recurrence
Nasopharynx
Randomized Controlled Trials

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Patamasucon, P., Rettig, P. J., Faust, K. L., Kusmiesz, H. T., & Nelson, J. D. (1982). Oral v. topical erythromycin therapies for chlamydial conjunctivitis. American Journal of Diseases of Children, 136(9), 817-821.

Oral v. topical erythromycin therapies for chlamydial conjunctivitis. / Patamasucon, P.; Rettig, P. J.; Faust, K. L.; Kusmiesz, H. T.; Nelson, J. D.

In: American Journal of Diseases of Children, Vol. 136, No. 9, 1982, p. 817-821.

Research output: Contribution to journalArticle

Patamasucon, P, Rettig, PJ, Faust, KL, Kusmiesz, HT & Nelson, JD 1982, 'Oral v. topical erythromycin therapies for chlamydial conjunctivitis', American Journal of Diseases of Children, vol. 136, no. 9, pp. 817-821.
Patamasucon, P. ; Rettig, P. J. ; Faust, K. L. ; Kusmiesz, H. T. ; Nelson, J. D. / Oral v. topical erythromycin therapies for chlamydial conjunctivitis. In: American Journal of Diseases of Children. 1982 ; Vol. 136, No. 9. pp. 817-821.
@article{6e21207982384e4dbff9c4dfbc22db40,
title = "Oral v. topical erythromycin therapies for chlamydial conjunctivitis",
abstract = "Results of oral and topical erythromycin therapy in 41 infants under 4 months of age with chlamydial conjunctivitis were evaluated in a randomized clinical trial. After three weeks of treatment, relapse or reinfection of the eye occurred in four of 19 patients (21{\%}) in the topical therapy group and in three of 22 patients (13.6{\%}) in the oral therapy group (P < .69). In the topical therapy group, chlamydiae were isolated from nasopharyngeal cultures of eight patients (42{\%}) during or after therapy. Chlamydiae were eradicated from the nasopharynx of the six colonized patients treated with oral erythromycin. All relapses responded to a course of oral erythromycin therapy. We conclude that both modes of therapy are comparable for treatment of chlamydial conjunctivitis, but that oral therapy has the advantage of eradicating nasopharyngeal colonization.",
author = "P. Patamasucon and Rettig, {P. J.} and Faust, {K. L.} and Kusmiesz, {H. T.} and Nelson, {J. D.}",
year = "1982",
language = "English (US)",
volume = "136",
pages = "817--821",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Oral v. topical erythromycin therapies for chlamydial conjunctivitis

AU - Patamasucon, P.

AU - Rettig, P. J.

AU - Faust, K. L.

AU - Kusmiesz, H. T.

AU - Nelson, J. D.

PY - 1982

Y1 - 1982

N2 - Results of oral and topical erythromycin therapy in 41 infants under 4 months of age with chlamydial conjunctivitis were evaluated in a randomized clinical trial. After three weeks of treatment, relapse or reinfection of the eye occurred in four of 19 patients (21%) in the topical therapy group and in three of 22 patients (13.6%) in the oral therapy group (P < .69). In the topical therapy group, chlamydiae were isolated from nasopharyngeal cultures of eight patients (42%) during or after therapy. Chlamydiae were eradicated from the nasopharynx of the six colonized patients treated with oral erythromycin. All relapses responded to a course of oral erythromycin therapy. We conclude that both modes of therapy are comparable for treatment of chlamydial conjunctivitis, but that oral therapy has the advantage of eradicating nasopharyngeal colonization.

AB - Results of oral and topical erythromycin therapy in 41 infants under 4 months of age with chlamydial conjunctivitis were evaluated in a randomized clinical trial. After three weeks of treatment, relapse or reinfection of the eye occurred in four of 19 patients (21%) in the topical therapy group and in three of 22 patients (13.6%) in the oral therapy group (P < .69). In the topical therapy group, chlamydiae were isolated from nasopharyngeal cultures of eight patients (42%) during or after therapy. Chlamydiae were eradicated from the nasopharynx of the six colonized patients treated with oral erythromycin. All relapses responded to a course of oral erythromycin therapy. We conclude that both modes of therapy are comparable for treatment of chlamydial conjunctivitis, but that oral therapy has the advantage of eradicating nasopharyngeal colonization.

UR - http://www.scopus.com/inward/record.url?scp=0019969865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019969865&partnerID=8YFLogxK

M3 - Article

C2 - 7051813

AN - SCOPUS:0019969865

VL - 136

SP - 817

EP - 821

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 9

ER -